Cheng Huang
ORCID：0000-0003-1358-6293
发表论文 159 篇 · 总被引 4091 次 · h-index 35
代表论文
- Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma (2025 · Cancer Discovery · 被引 11)
- First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study (2025 · Signal Transduction and Targeted Therapy · 被引 8)
- Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial (2025 · The Lancet. Gastroenterology & hepatology · 被引 6)
- Unveiling the dynamics and therapeutic potential of m 6 A methyltransferases and demethylases in liver diseases (2025 · International Journal of Biological Sciences · 被引 4)
- Tailoring Vascular‐Immune Homeostasis via Manganese‐DNA Complex‐Armed Immunogenic Extracellular Vesicles for Pancreatic Cancer Immunotherapy (2025 · Advanced Science · 被引 2)
- BRD2 promotes inflammation and lipid accumulation through the NF-κB pathway in alcoholic liver injury (2025 · Biochemical Pharmacology · 被引 2)